Table 2. Baseline characteristics and results of hormone assays in the study population.
| Auxological parameters | Patients (n = 194) | Control (n = 99) | P value |
|---|---|---|---|
| Age, yr | 8.08 ± 0.77 | 10.03 ± 0.58 | < 0.001 |
| Height, SDS | 1.25 ± 0.88 | 0.65 ± 1.18 | < 0.001 |
| Weight, SDS | 1.40 ± 1.25 | 1.17 ± 1.65 | 0.090 |
| BMI, SDS | 0.55 ± 1.01 | 0.70 ± 1.11 | 0.350 |
| MPH, SDS | −0.25 ± 0.75 | −0.08 ± 0.81 | 0.560 |
| BA, yr | 9.87 ± 0.98 | 10.55 ± 1.43 | 0.010 |
| BA advancement, yr | 1.79 ± 0.74 | 0.42 ± 1.13 | < 0.001 |
| SMR, stage | 2.55 ± 0.82 | ||
| Basal LH, IU/L | 0.62 ± 0.70 | ||
| Peak LH, IU/L | 13.80 ± 11.71 | ||
| Basal FSH, IU/L | 3.13 ± 3.54 | ||
| Peak FSH, IU/L | 15.12 ± 6.95 | ||
| Peak/basal LH | 50.91 ± 51.92 | ||
| Peak LH/FSH | 1.02 ± 0.82 | ||
| Estradiol, pg/mL | 6.55 ± 5.34 |
Data are shown as the mean ± standard deviation (SD).
SDS = standard deviation score, BMI = body mass index, MPH = mid parental height, BA = bone age, SMR = sexual maturity rating, LH = luteinizing hormone, FSH = follicle-stimulating hormone.